SacredBod
0
Boswellia Asthma (5-Lipoxygenase) — SacredBod supplement bottle (illustrative)
Supplement · Allergy & Histamine Control

Boswellia Asthma (5-Lipoxygenase)

300 mg · vegan · gluten-free · 60 caps

AsthmaWheezingShortness of breathChest tightnessExercise-induced bronchospasmAllergic airway inflammation LungsBronchiJoints
BUY on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

Overview Stacks Timing Related Research FAQs

What it is

Boswellia serrata (Indian frankincense or Salai guggal) gum resin contains boswellic acids — pentacyclic triterpenes that potently inhibit 5-lipoxygenase (5-LOX), the enzyme responsible for leukotriene synthesis. The H15 extract and other standardised formulations have demonstrated clinical benefits in bronchial asthma, osteoarthritis, and inflammatory bowel disease.

How it works

Acetyl-11-keto-β-boswellic acid (AKBA) and other boswellic acids bind to the 5-lipoxygenase enzyme and inhibit leukotriene B4 (LTB4) synthesis. Leukotrienes are potent bronchoconstrictors and inflammatory mediators in asthma. By blocking this pathway, boswellia reduces airway inflammation, bronchospasm, and mucus hypersecretion without the side effects of corticosteroids.

Who should take it

Adults with bronchial asthma, particularly those with exercise-induced or aspirin-exacerbated respiratory disease (AERD); individuals with allergic asthma seeking to reduce leukotriene-driven inflammation; and those with concurrent joint inflammation who want dual respiratory-musculoskeletal benefits.

Avoid / careful

Pregnant or breastfeeding women; individuals with bleeding disorders; those scheduled for surgery (discontinue 2 weeks prior). Side effects: Mild stomach upset, nausea, or diarrhoea in ~5% of users. Rare skin rash. Very well tolerated at standard doses.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

FAQs

Frequently asked

How long before I see results?
For asthma, expect 2–4 weeks before noticeable symptom improvement. The landmark Gupta trial showed that 70% of boswellia-treated patients had disappearance of physical symptoms (dyspnoea, rhonchi, attacks) and improvement in FEV1, FVC, and PEFR after 6 weeks. Only 27% of placebo patients improved. Eosinophil count and ESR also decreased significantly.
Can I replace my asthma inhaler with boswellia?
No. Boswellia is an adjunct, not a replacement for prescribed asthma medications. It addresses the leukotriene inflammatory pathway but does not provide acute bronchodilation. Continue your salbutamol and inhaled corticosteroids. Discuss adding boswellia with your pulmonologist.
Is it safe for long-term use?
Yes. Boswellia has been used safely for up to 12 months in osteoarthritis trials. The safety profile is excellent, with mild GI upset being the most common side effect. However, monitor if you are on anticoagulants.

In plain English

A plain-English read of the literature behind this supplement. Not a clinical recommendation.

Key citations: PMID 9810030 (Boswellia serrata gum resin in bronchial asthma — Gupta et al. 1998), PMID 11799030 (complementary butterbur evidence), PMID 15619563 (complementary Guduchi allergic rhinitis evidence)

Editorial notes

SacredBod's longer take on Boswellia Asthma (5-Lipoxygenase) — context the structured blocks above don't capture.

What Boswellia Asthma Is

Boswellia serrata, known in Sanskrit as Shallaki (शल्लकी) and in Hindi as Salai guggal (सलाई गुग्गल), is a tree native to India that produces a fragrant gum resin. This resin has been used in Ayurvedic medicine for millennia — referenced in the Sushruta Samhita for inflammatory conditions, joint diseases, and respiratory ailments.

The active compounds — boswellic acids (particularly AKBA, KBA, and β-boswellic acid) — are pentacyclic triterpenes that selectively inhibit 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid into leukotrienes. This mechanism is distinct from NSAIDs (which block COX) and makes boswellia particularly valuable for leukotriene-driven conditions like asthma and allergic rhinitis.

How It Works

  1. 5-LOX inhibition — AKBA is a direct, non-redox inhibitor of 5-lipoxygenase. It binds to the enzyme’s catalytic site, preventing the conversion of arachidonic acid to leukotriene A4 — the precursor to LTB4, LTC4, LTD4, and LTE4.
  2. Leukotriene reduction — Leukotrienes are 1,000× more potent than histamine in causing bronchoconstriction. By reducing LTB4 and cysteinyl leukotrienes, boswellia decreases airway hyperresponsiveness.
  3. Anti-inflammatory — Boswellic acids also inhibit NF-κB, TNF-α, and IL-6, reducing systemic and airway inflammation.
  4. Mucus reduction — Cysteinyl leukotrienes stimulate goblet cell mucus production. Blocking their synthesis reduces mucus hypersecretion in asthma.

Who Benefits Most

  • Asthma patients — The Gupta RCT demonstrated 70% improvement rate vs 27% placebo after 6 weeks.
  • Aspirin-exacerbated respiratory disease (AERD) — These patients have overactive leukotriene pathways; boswellia directly targets this pathology.
  • Exercise-induced asthma — Leukotrienes are major mediators of exercise-induced bronchospasm.
  • Individuals with joint + respiratory inflammation — Boswellia’s dual anti-inflammatory benefits address both osteoarthritis and asthma simultaneously.

Dosage Guide

GoalDoseDuration
Asthma support300 mg 3× daily (65% boswellic acids)6–12 weeks
General anti-inflammatory300–500 mg 2–3× dailyOngoing
Maintenance300 mg 2× dailyLong-term

Take with meals containing some fat to enhance absorption of the lipophilic boswellic acids.

Safety & Interactions

  • Bleeding: Theoretical risk with anticoagulants; discontinue 2 weeks before surgery.
  • Pregnancy: Not recommended.
  • NSAIDs: Additive anti-inflammatory effect; monitor for GI irritation.
  • Montelukast: Redundant mechanism; consult physician before combining.

India-Specific Context

  • Availability: Boswellia is widely available on Amazon.in. INLIFE Boswellia Serrata Extract 400mg (B07BGDFMML), HealthyHey Nutrition 65% boswellic acids (B07B7GSWY8 — currently unavailable), Morpheme Shallaki 500mg (B07C1DVG48), and turmeric+boswellia combos are all listed. Prices range from ₹300–₹800 for 60–120 capsules.
  • Regulatory status: Boswellia is sold as a dietary supplement and Ayurvedic medicine in India. It is not a Schedule H drug.
  • Ayurvedic heritage: Shallaki is a classical Vata-reducing herb in Ayurveda, used for Sandhigata Vata (osteoarthritis) and Shwasa (respiratory conditions). It is often combined with Guggulu in traditional formulations.
  • Indian research: The landmark asthma RCT was conducted in India (Gupta et al., 1998), demonstrating the strong local research foundation for this herb.
  • Cost-effectiveness: At ₹300–₹500 for a 2-month supply, boswellia is one of the most affordable and evidence-backed anti-inflammatory supplements in India.
Added to your stack.